Medicamen Biotech Limited (MEDICAMEQ) - Total Liabilities
Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has total liabilities worth Rs916.99 Million INR (≈ $9.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Medicamen Biotech Limited (MEDICAMEQ) equity growth momentum to track the company's year-over-year net asset growth rate.
Medicamen Biotech Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Medicamen Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. See MEDICAMEQ free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Medicamen Biotech Limited Competitors by Total Liabilities
The table below lists competitors of Medicamen Biotech Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cemat A/S
CO:CEMAT
|
Denmark | Dkr190.90 Million |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
Thailand | ฿2.70 Billion |
|
PetVivo Holdings Inc
NASDAQ:PETV
|
USA | $3.16 Million |
|
Wisr Ltd
AU:WZR
|
Australia | AU$976.80 Million |
|
Big Camera Corporation Public Company Limited
BK:BIG
|
Thailand | ฿1.09 Billion |
|
Tracxn Technologies Limited
NSE:TRACXN
|
India | Rs456.47 Million |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
USA | $66.80 Million |
|
5TH PLANET GAMES DK -50
F:2HG1
|
Germany | €12.60 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Medicamen Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medicamen Biotech Limited (MEDICAMEQ) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medicamen Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medicamen Biotech Limited (2006–2025)
The table below shows the annual total liabilities of Medicamen Biotech Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs841.04 Million ≈ $9.10 Million |
-3.95% |
| 2024-03-31 | Rs875.67 Million ≈ $9.47 Million |
+2.89% |
| 2023-03-31 | Rs851.03 Million ≈ $9.20 Million |
+7.42% |
| 2022-03-31 | Rs792.24 Million ≈ $8.57 Million |
+29.63% |
| 2021-03-31 | Rs611.18 Million ≈ $6.61 Million |
+1.75% |
| 2020-03-31 | Rs600.66 Million ≈ $6.50 Million |
+20.23% |
| 2019-03-31 | Rs499.59 Million ≈ $5.40 Million |
+16.34% |
| 2018-03-31 | Rs429.43 Million ≈ $4.64 Million |
-7.89% |
| 2017-03-31 | Rs466.20 Million ≈ $5.04 Million |
+10.71% |
| 2016-03-31 | Rs421.09 Million ≈ $4.55 Million |
-18.20% |
| 2015-03-31 | Rs514.78 Million ≈ $5.57 Million |
+7.15% |
| 2014-03-31 | Rs480.41 Million ≈ $5.20 Million |
-2.98% |
| 2013-03-31 | Rs495.17 Million ≈ $5.36 Million |
+1.46% |
| 2012-03-31 | Rs488.06 Million ≈ $5.28 Million |
-1.61% |
| 2011-03-31 | Rs496.06 Million ≈ $5.36 Million |
+19.76% |
| 2010-03-31 | Rs414.22 Million ≈ $4.48 Million |
+26.09% |
| 2009-03-31 | Rs328.50 Million ≈ $3.55 Million |
-18.26% |
| 2008-03-31 | Rs401.88 Million ≈ $4.35 Million |
+10.58% |
| 2007-03-31 | Rs363.44 Million ≈ $3.93 Million |
+43.93% |
| 2006-03-31 | Rs252.51 Million ≈ $2.73 Million |
-- |
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more